Piper Sandler analyst David Westenberg downgraded Exact Sciences (EXAS) to Neutral from Overweight with a $105 price target after the company announced an agreement to be acquired by Abbott (ABT) for $105 per share.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Booking, Carvana upgraded: Wall Street’s top analyst calls
- Exact Sciences downgraded to Hold from Buy at Benchmark
- Exact Sciences downgraded to Hold from Buy at Jefferies
- Exact Sciences Downgraded to Hold Amid ABT Acquisition and Market Uncertainties
- Cathie Wood Loads Up on CoreWeave (CRWV), and Crypto Stocks; Trims Stakes in GitLab, AMD, and Other Tech Stocks